Загрузка...
Palladium based nanoparticles for the treatment of advanced melanoma
IGF1R and CD44 are overexpressed in most advanced melanomas so we designed chemotherapeutic nanoparticles to target those receptors. Tris(dibenzylideneacetone)dipalladium (Tris DBA-Pd) is a novel inhibitor of N-myristoyltransferase 1 (NMT-1) and has proven in vivo activity against melanoma. However,...
Сохранить в:
| Опубликовано в: : | Sci Rep |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Publishing Group UK
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6397149/ https://ncbi.nlm.nih.gov/pubmed/30824801 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-40258-6 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|